IL-6 Antagonists and Uses thereof This application is a priority over US patent application 61 / 723,972 filed November 8, 2012 and US patent application 61 / 831,699 filed June 6, 2013. Claim rights. The entire contents of each of the earlier applications are hereby incorporated herein by reference.

摘要

IL-6 antagonists specific for binding of IL-6 to site II are provided. Disclosed are methods of using inhibitors to treat IL-6 related diseases, for example, eye diseases such as diabetic macular edema. [Selection figure] None